|
US3758475A
(en)
|
1971-07-20 |
1973-09-11 |
Sandoz Ag |
Pyrido(2,3-d)pyrimidin 2 ones
|
|
EP0081756B1
(en)
|
1981-12-14 |
1985-05-15 |
MEDEA RESEARCH S.r.l. |
New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions
|
|
IT1226048B
(it)
|
1981-12-14 |
1990-12-10 |
Medea Res Srl |
Composti ad attivita'antiinfiammatoria, processo per la loro preparazione e composizioni farmaceutiche relative
|
|
US4501729A
(en)
*
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
|
EP0278374A3
(de)
|
1987-02-06 |
1989-03-01 |
Pharmatest Apparatebau Gmbh |
Vorrichtung zur Bestimmung der Wirkstoff-Freigabe von pharmazeutischen Produkten
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5981714A
(en)
|
1990-03-05 |
1999-11-09 |
Genzyme Corporation |
Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
|
|
JP3167762B2
(ja)
|
1990-11-27 |
2001-05-21 |
武田薬品工業株式会社 |
ピリドピリダジン誘導体およびその用途
|
|
WO1993009763A1
(en)
|
1991-11-15 |
1993-05-27 |
Isp Investments Inc. |
Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
|
|
US5612360A
(en)
|
1992-06-03 |
1997-03-18 |
Eli Lilly And Company |
Angiotensin II antagonists
|
|
CA2107196A1
(en)
|
1992-09-29 |
1994-03-30 |
Mitsubishi Chemical Corporation |
Carboxamide derivatives
|
|
US6060024A
(en)
|
1993-07-14 |
2000-05-09 |
Zymark Corporation |
Automatic dissolution testing system
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
GB9317764D0
(en)
|
1993-08-26 |
1993-10-13 |
Pfizer Ltd |
Therapeutic compound
|
|
JPH09504028A
(ja)
|
1993-10-21 |
1997-04-22 |
ジー．ディー．サール アンド カンパニー |
酸化窒素シンターゼ抑制剤として有用なアミジノ誘導体
|
|
DE4405712A1
(de)
|
1994-02-23 |
1995-08-24 |
Basf Ag |
Substituierte Naphthyridine und deren Verwendung
|
|
NO305987B1
(no)
|
1994-04-11 |
1999-08-30 |
Sankyo Co |
Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
|
|
CZ289031B6
(cs)
|
1994-09-27 |
2001-10-17 |
Janssen Pharmaceutica N. V. |
Deriváty N-substituovaných piperidinylových bicyklických benzoátů
|
|
AU2788695A
(en)
|
1994-10-28 |
1996-05-23 |
Neurosearch A/S |
Patch clamp apparatus and technique having high throughput and low fluid volume requirements
|
|
US5656256A
(en)
*
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
|
US5510379A
(en)
|
1994-12-19 |
1996-04-23 |
Warner-Lambert Company |
Sulfonate ACAT inhibitors
|
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
WO1997036876A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US6849733B1
(en)
|
1996-08-23 |
2005-02-01 |
Agouron Pharmaceuticals, Inc. |
Neuropeptide-Y ligands
|
|
JP2002511054A
(ja)
|
1996-12-30 |
2002-04-09 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白トランスフェラーゼ阻害薬
|
|
CO4920215A1
(es)
|
1997-02-14 |
2000-05-29 |
Novartis Ag |
Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
|
|
US5948814A
(en)
|
1997-02-20 |
1999-09-07 |
The Curators Of The University Of Missouri |
Genistein for the treatment of cystic fibrosis
|
|
WO1998047868A1
(en)
|
1997-04-18 |
1998-10-29 |
Smithkline Beecham Plc |
Heterocycle-containing urea derivatives as 5ht1a, 5ht1b and 5ht1d receptor antagonists
|
|
RU2176999C2
(ru)
|
1997-10-02 |
2001-12-20 |
Санкио Компани, Лимитед |
Производные амидокарбоновой кислоты, фармацевтическая композиция на их основе и способ снижения глюкозы в крови
|
|
DK1054996T3
(da)
|
1998-02-17 |
2004-05-24 |
Searle & Co |
Fremgangsmåde til den enzymatiske adskillelse af lactamer
|
|
CN1311773A
(zh)
|
1998-06-08 |
2001-09-05 |
先灵公司 |
神经肽y5受体拮抗剂
|
|
US6426331B1
(en)
|
1998-07-08 |
2002-07-30 |
Tularik Inc. |
Inhibitors of STAT function
|
|
AUPP609198A0
(en)
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
|
US6444686B1
(en)
|
1998-12-18 |
2002-09-03 |
Brsitol-Myers Squibb Pharma Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
ES2226622T3
(es)
|
1999-02-24 |
2005-04-01 |
F. Hoffmann-La Roche Ag |
Derivados de 4-fenil piridina y su empleo como antagonistas del receptor nk-1.
|
|
WO2000050398A2
(en)
|
1999-02-24 |
2000-08-31 |
F. Hoffmann-La Roche Ag |
Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
|
|
BR0008494A
(pt)
|
1999-02-24 |
2002-02-05 |
Hoffmann La Roche |
Derivados de 3-fenilpiridina e seu uso como antagonista do receptor de nk-1
|
|
JP3472180B2
(ja)
|
1999-03-08 |
2003-12-02 |
日本電信電話株式会社 |
３次元周期構造体及び２次元周期構造体並びにそれらの作製方法
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
EP1194417A1
(de)
|
1999-06-18 |
2002-04-10 |
Bayer Ag |
Phenoxyfluorpyrimidine
|
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
|
WO2001046165A2
(en)
|
1999-12-16 |
2001-06-28 |
Novartis Ag |
N-heteroaryl-amides and their use as parasiticides
|
|
SK9742002A3
(en)
|
2000-01-07 |
2003-02-04 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
EP1253923A1
(en)
|
2000-01-28 |
2002-11-06 |
Biogen, Inc. |
Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
|
|
WO2001056989A2
(en)
|
2000-02-01 |
2001-08-09 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
WO2001081317A1
(en)
|
2000-04-26 |
2001-11-01 |
Gliatech, Inc. |
Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
|
|
AU2000249828A1
(en)
|
2000-05-03 |
2001-11-12 |
Taisho Pharmaceutical Co. Ltd. |
Stat4 and stat6 binding dipeptide derivatives
|
|
US6499984B1
(en)
|
2000-05-22 |
2002-12-31 |
Warner-Lambert Company |
Continuous production of pharmaceutical granulation
|
|
WO2001092235A1
(en)
|
2000-06-01 |
2001-12-06 |
Bristol-Myers Squibb Pharma Company |
LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
TWI259180B
(en)
|
2000-08-08 |
2006-08-01 |
Hoffmann La Roche |
4-Phenyl-pyridine derivatives
|
|
AU2001296871A1
(en)
|
2000-09-15 |
2002-03-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
US20020115619A1
(en)
|
2000-10-04 |
2002-08-22 |
Rubenstein Ronald C. |
Compositions and methods for treatment of cystic fibrosis
|
|
GB2367816A
(en)
|
2000-10-09 |
2002-04-17 |
Bayer Ag |
Urea- and thiourea-containing derivatives of beta-amino acids
|
|
ATE269856T1
(de)
|
2000-10-20 |
2004-07-15 |
Merck Patent Gmbh |
Chirale binaphtol-verbindungen
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
ATE478664T1
(de)
|
2000-12-01 |
2010-09-15 |
Eisai Inc |
Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
|
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
|
US6531597B2
(en)
|
2001-02-13 |
2003-03-11 |
Hoffmann-La Roche Inc. |
Process for preparation of 2-phenyl acetic acid derivatives
|
|
US6962674B2
(en)
|
2001-02-28 |
2005-11-08 |
Varian, Inc. |
Dissolution test apparatus
|
|
JP2005520171A
(ja)
|
2001-04-10 |
2005-07-07 |
トランス テック ファーマ，インコーポレイテッド |
ドラッグディスカバリーに関する、プローブ、システム、および方法
|
|
DK1385577T3
(da)
|
2001-04-23 |
2006-08-21 |
Hoffmann La Roche |
Anvendelse af NK-1-receptorantagonister mod godartet prostatahyperplasi
|
|
CA2448198A1
(en)
|
2001-05-22 |
2002-12-05 |
Neurogen Corporation |
5-substituted-2-arylpyridines as crf1 modulators
|
|
US20030083345A1
(en)
|
2001-07-10 |
2003-05-01 |
Torsten Hoffmann |
Method of treatment and/or prevention of brain, spinal or nerve injury
|
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
WO2003007888A2
(en)
|
2001-07-20 |
2003-01-30 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
|
CA2448737C
(en)
|
2001-07-20 |
2010-06-01 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
EP1425284A2
(en)
|
2001-09-11 |
2004-06-09 |
Smithkline Beecham Corporation |
Furo- and thienopyrimidine derivatives as angiogenesis inhibitors
|
|
PA8557501A1
(es)
|
2001-11-12 |
2003-06-30 |
Pfizer Prod Inc |
Benzamida, heteroarilamida y amidas inversas
|
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
|
JP2003221386A
(ja)
|
2001-11-26 |
2003-08-05 |
Takeda Chem Ind Ltd |
二環性誘導体、その製造法およびその用途
|
|
EP1458382A1
(en)
|
2001-12-21 |
2004-09-22 |
Novo Nordisk A/S |
Amide derivatives as gk activators
|
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
FR2840807B1
(fr)
|
2002-06-12 |
2005-03-11 |
|
Composition cosmetique de soin et/ou de maquillage, structuree par des polymeres silicones et des organogelateurs, sous forme rigide
|
|
PL374971A1
(en)
|
2002-08-09 |
2005-11-14 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
|
WO2004028480A2
(en)
|
2002-09-30 |
2004-04-08 |
The Regents Of The University Of California |
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
|
|
JP3546208B2
(ja)
|
2002-10-02 |
2004-07-21 |
明治製菓株式会社 |
経口吸収性が改善された抗菌性医薬組成物
|
|
EP1554271A1
(en)
|
2002-10-15 |
2005-07-20 |
Rigel Pharmaceuticals, Inc. |
Substituted indoles and their use as hcv inhibitors
|
|
US7514431B2
(en)
|
2002-10-30 |
2009-04-07 |
Merck & Co., Inc. |
Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
|
|
WO2004040295A1
(en)
|
2002-10-31 |
2004-05-13 |
Nanostream, Inc. |
Parallel detection chromatography systems
|
|
US7910030B2
(en)
|
2002-11-26 |
2011-03-22 |
Universiteit Gent |
Process and apparatus for continuous wet granulation of powder material
|
|
BR0317183A
(pt)
|
2002-12-12 |
2005-11-01 |
Pharmacia Corp |
Método de usar compostos de aminocianopiridina como inibidores de proteìna quinase-2 ativada por proteìna quinase ativada por mitógeno
|
|
WO2004063179A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Substituted arylcyclopropylacetamides as glucokinase activators
|
|
MXPA05008450A
(es)
|
2003-02-10 |
2005-10-18 |
Vertex Pharma |
Procesos para la preparacion de n-heteroaril-n-aril-aminas mediante reaccion de un ester de acido n-aril-carbamico con un halo-heteroarilo y procesos analogos.
|
|
US7223788B2
(en)
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
US20050113423A1
(en)
|
2003-03-12 |
2005-05-26 |
Vangoor Frederick F. |
Modulators of ATP-binding cassette transporters
|
|
DK3549936T3
(da)
|
2003-04-11 |
2021-07-12 |
Ptc Therapeutics Inc |
1,2,4-oxadiazol-benzoesyreforbindelse og dens anvendelse til nonsense-undertrykkelse og behandlingen af sygdom
|
|
US7358364B2
(en)
|
2003-04-30 |
2008-04-15 |
The Institute For Pharmaceutical Discovery Llc |
Substituted carboxylic acids
|
|
WO2004110352A2
(en)
|
2003-05-16 |
2004-12-23 |
The Regents Of The University Of California |
Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
|
|
ATE440825T1
(de)
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
AU2004253541B2
(en)
|
2003-06-27 |
2010-10-28 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Amphiphilic pyridinium compounds, method of making and use thereof
|
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
|
JP2005053902A
(ja)
|
2003-07-18 |
2005-03-03 |
Nippon Nohyaku Co Ltd |
フェニルピリジン類、その中間体及びこれを有効成分とする除草剤
|
|
CN1878773A
(zh)
|
2003-09-05 |
2006-12-13 |
神经能质公司 |
作为crf1受体配位体的杂芳基稠合的吡啶,吡嗪及嘧啶
|
|
RU2006111093A
(ru)
|
2003-09-06 |
2007-10-27 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Модуляторы атр-связывающих кассетных транспортеров
|
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
|
US20050070718A1
(en)
|
2003-09-30 |
2005-03-31 |
Abbott Gmbh & Co. Kg |
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
|
|
EP1680411A2
(en)
|
2003-10-08 |
2006-07-19 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
|
|
EP1679069A4
(en)
|
2003-10-21 |
2009-05-13 |
Dainippon Sumitomo Pharma Co |
NEW PIPERIDINE DERIVATIVE
|
|
FR2861304B1
(fr)
|
2003-10-23 |
2008-07-18 |
Univ Grenoble 1 |
Modulateurs des canaux cftr
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
CA2545719A1
(en)
|
2003-11-14 |
2005-06-02 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
|
|
JP2007511572A
(ja)
|
2003-11-19 |
2007-05-10 |
グラクソ グループ リミテッド |
統合失調症治療のためのシクロオキシゲナーゼ−２選択的阻害剤の使用
|
|
JP3746062B2
(ja)
|
2003-12-05 |
2006-02-15 |
第一製薬株式会社 |
固形製剤およびその製造方法
|
|
ES2238001B1
(es)
|
2004-01-21 |
2006-11-01 |
Vita Cientifica, S.L. |
Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
|
|
WO2005075435A1
(en)
|
2004-01-30 |
2005-08-18 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
US7522995B2
(en)
|
2004-02-05 |
2009-04-21 |
Nortrup Edward H |
Method and system for providing travel time information
|
|
AU2005214225B2
(en)
|
2004-02-19 |
2010-05-20 |
Banyu Pharmaceutical Co., Ltd. |
Novel sulfone amide derivative
|
|
PL2156824T3
(pl)
|
2004-03-25 |
2013-03-29 |
Astellas Pharma Inc |
Kompozycja solifenacyny lub jej soli do zastosowania w formulacji stałej
|
|
CA2561560A1
(en)
|
2004-03-30 |
2005-10-13 |
The Regents Of The University Of California |
Hydrazide-containing cftr inhibitor compounds and uses thereof
|
|
ES2241496B1
(es)
|
2004-04-15 |
2006-12-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridina.
|
|
US20080015196A1
(en)
|
2004-04-16 |
2008-01-17 |
Neurogen Corporation |
Imidazopyrazines, Imidazopyridines, and Imidazopyrimidines as Crf1 Receptor Ligands
|
|
US7585885B2
(en)
|
2004-04-22 |
2009-09-08 |
Eli Lilly And Company |
Pyrrolidine derivatives useful as BACE inhibitors
|
|
US7618978B2
(en)
|
2004-04-22 |
2009-11-17 |
Eli Lilly And Company |
Amides as BACE inhibitors
|
|
CA2568499A1
(en)
|
2004-06-01 |
2005-12-15 |
Tm Bioscience Corporation |
Method of detecting cystic fibrosis associated mutations
|
|
AU2005251745A1
(en)
|
2004-06-04 |
2005-12-22 |
The Regents Of The University Of California |
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
|
|
TWI547431B
(zh)
|
2004-06-09 |
2016-09-01 |
史密斯克萊美占公司 |
生產藥物之裝置及方法
|
|
US20140343098A1
(en)
|
2004-06-24 |
2014-11-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
PL2489659T3
(pl)
|
2004-06-24 |
2018-06-29 |
Vertex Pharma |
Modulatory transporterów posiadających kasetę wiążącą atp
|
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
EP1781253A1
(en)
|
2004-07-01 |
2007-05-09 |
Warner-Lambert Company LLC |
Preparation of pharmaceutical compositions containing nanoparticles
|
|
EP1771158A4
(en)
|
2004-07-02 |
2008-03-12 |
Advancis Pharmaceutical Corp |
TABLET FOR PULSE DISTRIBUTION
|
|
EP1773797A2
(en)
|
2004-08-06 |
2007-04-18 |
Otsuka Pharmaceutical Co., Ltd. |
Aromatic compounds
|
|
AU2005289426A1
(en)
|
2004-09-27 |
2006-04-06 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
AU2005293336B2
(en)
|
2004-10-12 |
2009-05-28 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
EP2402323A3
(en)
|
2004-10-13 |
2012-05-30 |
PTC Therapeutics, Inc. |
Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
|
|
JP5036126B2
(ja)
|
2004-10-19 |
2012-09-26 |
日医工株式会社 |
エバスチン経口投与用製剤
|
|
WO2006051394A1
(en)
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles for the treatment of cns disorders
|
|
AU2005315591B2
(en)
|
2004-12-15 |
2011-03-17 |
Dompe' Farmaceutici S.P.A. |
2-arylpropionic acid derivatives and pharmaceutical compositions containing them
|
|
JP4790260B2
(ja)
|
2004-12-22 |
2011-10-12 |
出光興産株式会社 |
アントラセン誘導体を用いた有機エレクトロルミネッセンス素子
|
|
KR101276987B1
(ko)
|
2005-01-25 |
2013-06-25 |
바이엘 크롭사이언스 아게 |
아인산, 포세틸-ａｌ 또는 두 가지 모두의 동시적 분석방법
|
|
EP1844003A4
(en)
|
2005-01-27 |
2010-09-22 |
Astrazeneca Ab |
NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
|
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
|
EP1845081A4
(en)
|
2005-02-01 |
2009-03-25 |
Takeda Pharmaceutical |
amide
|
|
US8242149B2
(en)
|
2005-03-11 |
2012-08-14 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
WO2006101740A2
(en)
|
2005-03-18 |
2006-09-28 |
The Regents Of The University Of California |
Compounds having activity in correcting mutant-cftr processing and uses thereof
|
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
TWI377206B
(en)
*
|
2005-04-06 |
2012-11-21 |
Theravance Inc |
Crystalline form of a quinolinone-carboxamide compound
|
|
ES2683359T3
(es)
|
2005-04-08 |
2018-09-26 |
Ptc Therapeutics, Inc. |
Composiciones que comprenden un 1,2,4-oxadiazol y usos de las mismas para tratar enfermedades asociadas con un codón de parada prematura
|
|
EP1710246A1
(en)
|
2005-04-08 |
2006-10-11 |
Schering Aktiengesellschaft |
Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer
|
|
JP2008536950A
(ja)
|
2005-04-18 |
2008-09-11 |
ニューロジェン・コーポレーション |
置換ヘテロアリールのｃｂ１拮抗薬
|
|
BRPI0610850A2
(pt)
|
2005-04-19 |
2008-12-02 |
Bayer Pharmaceuticals Corp |
derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
|
|
CN101160126A
(zh)
*
|
2005-04-20 |
2008-04-09 |
默克公司 |
血管紧张肽ⅱ受体拮抗剂
|
|
GT200600158A
(es)
*
|
2005-04-22 |
2006-11-28 |
|
Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
ATE533749T1
(de)
|
2005-05-24 |
2011-12-15 |
Vertex Pharma |
Modulatoren von atp-bindenden kassettentransportern
|
|
AU2006252768A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
|
WO2006136829A2
(en)
|
2005-06-21 |
2006-12-28 |
Astex Therapeutics Limited |
Pyrazole derivatives and their use as pka and pkb modulators
|
|
KR20080053297A
(ko)
|
2005-08-11 |
2008-06-12 |
버텍스 파마슈티칼스 인코포레이티드 |
낭포성 섬유종 트랜스막 전도도 조정자의 조절자
|
|
ES2367844T3
(es)
|
2005-08-11 |
2011-11-10 |
Vertex Pharmaceuticals, Inc. |
Moduladores del regulador de la conductancia transmembrana de la fibrosis quística.
|
|
US7683056B2
(en)
|
2005-09-09 |
2010-03-23 |
Glaxosmithkline Llc |
Pyridine derivatives and their use in the treatment of psychotic disorders
|
|
WO2007039420A1
(en)
|
2005-09-23 |
2007-04-12 |
F. Hoffmann-La Roche Ag |
Novel dosage formulation
|
|
CA2624683A1
(en)
|
2005-10-06 |
2007-04-19 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
CN103382176A
(zh)
|
2005-10-19 |
2013-11-06 |
格吕伦塔尔有限公司 |
新颖的辣椒素受体配体和它们用于生产药物的用途
|
|
WO2007054480A1
(en)
|
2005-11-08 |
2007-05-18 |
N.V. Organon |
2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
|
|
US20120232059A1
(en)
|
2005-11-08 |
2012-09-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette Transporters
|
|
DK2774925T3
(en)
|
2005-11-08 |
2017-02-27 |
Vertex Pharma |
Heterocyclic modulators of ATP binding cassette transporters
|
|
GB0606891D0
(en)
|
2006-04-05 |
2006-05-17 |
Council Cent Lab Res Councils |
Raman Analysis Of Pharmaceutical Tablets
|
|
JP5103403B2
(ja)
|
2005-12-05 |
2012-12-19 |
スミスクライン ビーチャム コーポレーション |
２−ピリミジニルピラゾロピリジンＥｒｂＢキナーゼ阻害剤
|
|
EP1979367A2
(en)
|
2005-12-24 |
2008-10-15 |
Vertex Pharmaceuticals Incorporated |
Quinolin-4-one derivatives as modulators of abc transporters
|
|
EP1974212A1
(en)
|
2005-12-27 |
2008-10-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful in cftr assays and methods therewith
|
|
NZ569327A
(en)
|
2005-12-28 |
2011-09-30 |
Vertex Pharma |
1-(benzo [d] [1,3] dioxol-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis
|
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
PT1993360T
(pt)
|
2005-12-28 |
2017-05-25 |
Vertex Pharma |
Formas sólidas de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-di-hidro-4-oxoquinolina-3-carboxamida
|
|
WO2007079257A2
(en)
|
2005-12-30 |
2007-07-12 |
Caliper Life Sciences, Inc. |
Integrated dissolution processing and sample transfer system
|
|
US10022352B2
(en)
|
2006-04-07 |
2018-07-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
US7645789B2
(en)
|
2006-04-07 |
2010-01-12 |
Vertex Pharmaceuticals Incorporated |
Indole derivatives as CFTR modulators
|
|
ES2882684T3
(es)
|
2006-04-07 |
2021-12-02 |
Vertex Pharma |
Preparación de moduladores de transportadores del casete de unión a ATP
|
|
JP2009536969A
(ja)
|
2006-05-12 |
2009-10-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｎ−［２，４−ビス（１，１−ジメチルエチル）−５−ヒドロキシフェニル］−１，４−ジヒドロ−４−オキソキノリン−３−カルボキサミド組成物
|
|
JP2009537478A
(ja)
|
2006-05-13 |
2009-10-29 |
ノヴォ ノルディスク アクティーゼルスカブ |
レパグリニドとメトホルミンを含む錠剤配合物
|
|
EP2826778B1
(en)
|
2006-11-03 |
2017-09-20 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
|
JP5318400B2
(ja)
|
2006-11-20 |
2013-10-16 |
第一三共株式会社 |
レボフロキサシン含有錠剤
|
|
KR20090083408A
(ko)
|
2006-11-27 |
2009-08-03 |
노파르티스 아게 |
치환된 디히드로이미다졸 및 종양 치료에서의 그의 용도
|
|
JP5023716B2
(ja)
|
2007-01-25 |
2012-09-12 |
カシオ計算機株式会社 |
蒸発型ゲッター材、ゲッターポンプ、減圧構造、反応装置、発電装置及び電子機器
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EA020045B1
(ru)
|
2007-05-02 |
2014-08-29 |
Портола Фармасьютиклз, Инк. |
Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах
|
|
NZ581259A
(en)
|
2007-05-09 |
2012-07-27 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
NZ581419A
(en)
|
2007-05-25 |
2012-05-25 |
Vertex Pharma |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
US20110177999A1
(en)
|
2007-08-09 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Therapeutic Combinations Useful in Treating CFTR Related Diseases
|
|
ES2578735T3
(es)
|
2007-08-24 |
2016-07-29 |
Vertex Pharmaceuticals Incorporated |
Isotiazolopiridinonas útiles para el tratamiento de (entre otros) fibrosis quística
|
|
DE102007042754A1
(de)
|
2007-09-07 |
2009-03-12 |
Bayer Healthcare Ag |
Substituierte 6-Phenylnikotinsäuren und ihre Verwendung
|
|
BRPI0816345A2
(pt)
|
2007-09-14 |
2015-02-24 |
Vertex Pharma |
Formas sólidas de n-[2,4-bis-(1,1-dimetiletil)-5-hidroxifenil]-1,4-diidro-4-o xoquinolin-3-carboxamida
|
|
AU2008298545B2
(en)
|
2007-09-14 |
2013-12-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
US8118283B2
(en)
|
2007-09-21 |
2012-02-21 |
Lanny Vlasak |
Apparatus for aerating an aqueous solution
|
|
FR2921657A1
(fr)
|
2007-09-28 |
2009-04-03 |
Sanofi Aventis Sa |
Derives de nicotinamide, leur preparation et leur application en therapeutique
|
|
EP2578571B1
(en)
|
2007-11-16 |
2015-09-16 |
Vertex Pharmaceuticals Incorporated |
Isoquinoline modulators of ATP-binding cassette transporters
|
|
DE102007058718A1
(de)
|
2007-12-06 |
2009-06-10 |
Erweka Gmbh |
Vorrichtung und Verfahren zur automatischen Freisetzung und Messung von Wirkstoffen aus einer Arzneizubereitung
|
|
US20100036130A1
(en)
|
2007-12-07 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
|
AU2008335439A1
(en)
|
2007-12-07 |
2009-06-18 |
Vertex Pharmaceuticals Incorporated |
Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
|
AU2008335440B2
(en)
|
2007-12-07 |
2013-11-07 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
|
CN103626744B
(zh)
|
2007-12-07 |
2016-05-11 |
沃泰克斯药物股份有限公司 |
3-(6-(1-(2,2-二氟苯并[d][1,3]间二氧杂环戊烯-5-基)环丙烷甲酰氨基)-3-甲基吡啶-2-基)苯甲酸的固体形式
|
|
NZ586271A
(en)
|
2007-12-13 |
2012-08-31 |
Vertex Pharma |
Fused pyrimidinone derivatives as modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN101939009B
(zh)
|
2008-02-05 |
2013-07-17 |
哈博生物科学公司 |
药学固体形式
|
|
JP5523352B2
(ja)
|
2008-02-28 |
2014-06-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｃｆｔｒ修飾因子としてのへテロアリール誘導体
|
|
US8343774B2
(en)
|
2008-02-29 |
2013-01-01 |
Waters Technologies Corporation |
Chromatography-based monitoring and control of multiple process streams
|
|
PT2615085E
(pt)
|
2008-03-31 |
2015-10-09 |
Vertex Pharma |
Derivados piridilo como moduladores cftr
|
|
GB0813709D0
(en)
|
2008-07-26 |
2008-09-03 |
Univ Dundee |
Method and product
|
|
US20100256184A1
(en)
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
KR20110042356A
(ko)
|
2008-08-13 |
2011-04-26 |
버텍스 파마슈티칼스 인코포레이티드 |
제약 조성물 및 그의 투여
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
BRPI0919550A2
(pt)
|
2008-09-29 |
2019-09-10 |
Vertex Pharma |
unidades de dosagem de ácido 3-(6-(1-(2,2-difluorobenzo]d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico
|
|
US8314239B2
(en)
|
2008-10-23 |
2012-11-20 |
Vertex Pharmaceutical Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
SI2349263T1
(sl)
|
2008-10-23 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Modulatorji cistiäśno-fibroznega transmembranskega regulatorja prevodnosti
|
|
US8436014B2
(en)
|
2008-10-23 |
2013-05-07 |
Vertex Pharmaceutical Incorporated |
Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
|
|
US20110257223A1
(en)
|
2008-10-23 |
2011-10-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
|
|
CA2740836C
(en)
|
2008-10-31 |
2017-03-21 |
Biomerieux, Inc. |
Methods for separation, characterization and/or identification of microorganisms using spectroscopy
|
|
KR20160013251A
(ko)
|
2008-11-06 |
2016-02-03 |
버텍스 파마슈티칼스 인코포레이티드 |
Ａｔｐ-결합 카세트 수송자의 조절자
|
|
UA104876C2
(uk)
|
2008-11-06 |
2014-03-25 |
Вертекс Фармасьютікалз Інкорпорейтед |
Модулятори atф-зв'язувальних касетних транспортерів
|
|
WO2010078103A1
(en)
|
2008-12-30 |
2010-07-08 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
EP3330255B1
(en)
|
2009-03-20 |
2020-12-09 |
Vertex Pharmaceuticals Incorporated |
Process for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
ES2683633T3
(es)
|
2009-03-20 |
2018-09-27 |
Vertex Pharmaceuticals Incorporated |
Moduladores de regulador de conductancia transmembrana de la fibrosis quística
|
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
|
JP2012525895A
(ja)
|
2009-05-07 |
2012-10-25 |
ジーイーエイ・ファーマ・システムズ・リミテッド |
錠剤の製造モジュール及び錠剤の連続製造方法
|
|
JP5355269B2
(ja)
|
2009-07-16 |
2013-11-27 |
大日本住友製薬株式会社 |
顕微ラマン分光法による固体材料中の分散粒子の粒径の測定法
|
|
BR112012006031A2
(pt)
|
2009-09-17 |
2019-09-24 |
Vertex Pharma |
processo para preparação de compostos azabicíclicos.
|
|
MX2012004792A
(es)
|
2009-10-22 |
2013-02-01 |
Vertex Pharma |
Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
|
|
CN102648182A
(zh)
|
2009-10-23 |
2012-08-22 |
沃泰克斯药物股份有限公司 |
用于制备囊性纤维化跨膜传导调节因子的调节剂的方法
|
|
JP5877157B2
(ja)
|
2009-10-23 |
2016-03-02 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ｎ−（４−（７−アザビシクロ［２．２．１］ヘプタン−７−イル）−２−（トリフルオロメチル）フェニル）−４−オキソ−５−（トリフルオロメチル）−１，４−ジヒドロキノリン−３−カルボキサミドの固体形態
|
|
AU2011227021A1
(en)
|
2010-03-19 |
2012-10-18 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
ES2845449T3
(es)
|
2010-03-25 |
2021-07-26 |
Vertex Pharma |
Dispersión sólida de forma amorfa de (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-il)-N-(1-(2,3-dihidroxipropil)-6-fluoro-2(1-hidroxi-2-metilpropan-2-il)-1h-indol-5il)-ciclopropanocarboxamida
|
|
EP2555755B2
(en)
|
2010-04-07 |
2019-07-10 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
|
|
AR081069A1
(es)
|
2010-04-07 |
2012-06-06 |
Vertex Pharma |
Formas solidas del acido 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benzoico
|
|
AU2011242452A1
(en)
|
2010-04-22 |
2012-11-08 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
RU2569678C2
(ru)
|
2010-04-22 |
2015-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения циклоалкилкарбоксамидо-индольных соединений
|
|
CA2796646A1
(en)
|
2010-04-22 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
NZ603043A
(en)
|
2010-04-22 |
2015-02-27 |
Vertex Pharma |
Pharmaceutical compositions comprising cftr modulators and administrations thereof
|
|
NZ603386A
(en)
|
2010-05-20 |
2015-02-27 |
Vertex Pharma |
Pharmaceutical compositions and administrations thereof
|
|
AR081920A1
(es)
|
2010-05-20 |
2012-10-31 |
Vertex Pharma |
Procesos de produccion de moduladores del regulador de conductancia transmembrana de fibrosis quistica
|
|
US8563593B2
(en)
|
2010-06-08 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
|
|
CA2808501A1
(en)
|
2010-08-23 |
2012-03-01 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
|
|
RU2013113627A
(ru)
|
2010-08-27 |
2014-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтическая композиция и ее введения
|
|
CN102058889A
(zh)
|
2010-11-05 |
2011-05-18 |
王定豪 |
包含抗凝血类药物的分散片及其应用
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
JP5798400B2
(ja)
|
2011-07-26 |
2015-10-21 |
富士電機株式会社 |
医薬品製造制御装置、医薬品製造制御方法、医薬品製造制御プログラム、医薬品製造システム
|
|
CN102507770A
(zh)
|
2011-10-25 |
2012-06-20 |
中国检验检疫科学研究院 |
检测化妆品中六氯酚的高效液相色谱法
|
|
CN103073508B
(zh)
*
|
2011-10-25 |
2016-06-01 |
北京大学深圳研究生院 |
激酶抑制剂及治疗相关疾病的方法
|
|
EP2773349A1
(en)
|
2011-11-02 |
2014-09-10 |
Vertex Pharmaceuticals Incorporated |
Use of (n- [2, 4 -bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl]- 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide) for treating cftr mediated diseases
|
|
US20140127901A1
(en)
|
2012-11-08 |
2014-05-08 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Low-k damage free integration scheme for copper interconnects
|
|
US9254291B2
(en)
|
2011-11-08 |
2016-02-09 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
SMT201900451T1
(it)
|
2012-01-25 |
2019-11-13 |
Vertex Pharma |
Formulazioni di acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]diossol-5-il) ciclopropancarbossammido)-3-metilpiridin-2-il)benzoico
|
|
IL311180A
(en)
|
2012-02-27 |
2024-04-01 |
Vertex Pharma |
Pharmaceutical preparations containing a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and uses thereof
|
|
US8674108B2
(en)
|
2012-04-20 |
2014-03-18 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
JP2013253790A
(ja)
|
2012-06-05 |
2013-12-19 |
Chube Univ |
ニバレノールの分析法
|
|
CA2874851A1
(en)
|
2012-06-08 |
2013-12-12 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of cftr-mediated disorders
|
|
US9012496B2
(en)
|
2012-07-16 |
2015-04-21 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof
|
|
US20140092376A1
(en)
|
2012-10-01 |
2014-04-03 |
Momentive Performance Materials, Inc. |
Container and method for in-line analysis of protein compositions
|
|
TWI736768B
(zh)
|
2012-11-02 |
2021-08-21 |
美商維泰克斯製藥公司 |
治療cftr介導疾病之醫藥組合物
|
|
US9636301B2
(en)
|
2012-12-04 |
2017-05-02 |
Arbutus Biopharma Corporation |
In vitro release assay for liposome encapsulated vincristine
|
|
US20140221424A1
(en)
|
2013-01-30 |
2014-08-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for use in the treatment of cystic fibrosis
|
|
CN103743826B
(zh)
|
2013-08-28 |
2015-12-02 |
合肥久诺医药科技有限公司 |
一种阿齐沙坦的高效液相色谱分析方法
|
|
CN103822976B
(zh)
|
2013-10-15 |
2015-05-27 |
辽宁省食品药品检验所 |
一种测定化妆品中4-甲氧基水杨酸钾的方法
|
|
HRP20210516T2
(hr)
|
2013-11-12 |
2021-10-01 |
Vertex Pharmaceuticals Incorporated |
Postupak proizvodnje farmaceutskih pripravaka za liječenje bolesti koje su posredovane putem cftr
|
|
PT3131582T
(pt)
|
2014-04-15 |
2018-10-08 |
Vertex Pharma |
Composições farmacêuticas para o tratamento de doenças mediadas pelo regulador de condutância transmembranar da fibrose quística
|
|
CN104090038B
(zh)
|
2014-07-07 |
2015-09-30 |
黄宏南 |
一种直接测定冬虫夏草产品中冬虫夏草多糖肽含量的方法
|
|
CN104122346B
(zh)
|
2014-07-31 |
2016-03-16 |
国家烟草质量监督检验中心 |
一种水基胶中尿素含量的测定方法
|
|
CN104122345B
(zh)
|
2014-07-31 |
2015-08-12 |
国家烟草质量监督检验中心 |
烟用纸中1,1,1-三羟甲基丙烷的测定方法
|
|
PT3203840T
(pt)
|
2014-10-06 |
2020-10-27 |
Vertex Pharma |
Moduladores do regulador da condutância transmembranar da fibrose quística
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|
|
DK3221692T3
(da)
|
2014-11-18 |
2021-08-23 |
Vertex Pharma |
Fremgangsmåde til udførsel af tests med høj kapacitet ved hjælp af højtryksvæskekromatografi
|
|
WO2016086136A1
(en)
|
2014-11-26 |
2016-06-02 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders
|
|
MA41031A
(fr)
|
2014-11-26 |
2017-10-03 |
Catabasis Pharmaceuticals Inc |
Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie
|
|
WO2016087665A2
(en)
|
2014-12-05 |
2016-06-09 |
Centre National De La Recherche Scientifique (Cnrs) |
Compounds for treating cystic fibrosis
|
|
US10255481B2
(en)
|
2015-01-07 |
2019-04-09 |
Samsung Electronics Co., Ltd. |
Display device and operating method thereof with adjustments display
|
|
ES2749097T3
(es)
|
2015-01-26 |
2020-03-19 |
Rigel Pharmaceuticals Inc |
Tetrazolonas como bioisósteros de ácido carboxílico
|
|
TWI730959B
(zh)
|
2015-05-19 |
2021-06-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺
|
|
CN105890945A
(zh)
|
2016-04-01 |
2016-08-24 |
中国热带农业科学院分析测试中心 |
超声离心渗液进样快速测定土壤中速效钾的方法
|
|
US20180280349A1
(en)
|
2017-03-28 |
2018-10-04 |
Vertex Pharmaceuticals Incorporated |
Methods of treating cystic fibrosis in patients with residual function mutations
|